References
Gachaly B, Vas A, Hajos P, Kaldor A (1984) Acetylator phenotypes: effect of age. Eur J Clin Pharmacol 26: 43–45
Farah F, Taylor W, Rawlins MD, James O (1977) Hepatic drug acetylation and oxidation: effects of ageing in man. Br Med J 2: 155–156
Cartwright RA, Glashan RW, Rogers HJ, Ahmad RA, Barham-Hall D, Higgins E, Kahn MA (1982) Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2: 842–846
Evans DAP (1969) An improved and simplified method of detecting the acetylator phenotype. J Med Genet 6: 405–407
Evans DAP, White TA (1964) Human acetylation polymorphism. J Lab Clin Med 63: 394–403
Varley M (1954) Practical clinical biochemistry. Heinemann Medical Books, London, pp 632–636
Burrows AW, Hockaday TDR, Mann JI, Taylor JG (1978) Diabetic dimorphism according to acetylator status. Br Med J 1: 208–210
Vree TB, O'Reilly WJ, Hekster YA, Damsma JE, van der Kleijn E (1980) Determination of acetylator phenotype and pharmacokinetics of some sulphonamides in man. Clin Pharmacokinet 5: 274–294
Lunde PKM, Frislid K, Hausteen V (1977) Disease and acetylation polymorphism. Clin Pharmacokinet 2: 182–197
Author information
Authors and Affiliations
About this article
Cite this article
Pontiroli, A.E., De Pasqua, A., Bonisolli, L. et al. Ageing and acetylator phenotype as determined by administration of sulphadimidine. Eur J Clin Pharmacol 28, 485–486 (1985). https://doi.org/10.1007/BF00544374
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00544374